INTEST CORP·4

Mar 18, 5:01 PM ET

DEWS JOSEPH W IV 4

4 · INTEST CORP · Filed Mar 18, 2026

Research Summary

AI-generated summary of this filing

Updated

INTEST (INTT) Director Joseph W. Dews IV Receives 12,000-Share Award

What Happened

  • Joseph W. Dews IV, a director of INTEST CORP (INTT), was granted 12,000 shares on 2026-03-16. The filing reports an acquisition (transaction code A) of 12,000 shares at $0.00 per share (total $0), indicating a stock award or similar compensation grant rather than an open-market purchase.

Key Details

  • Transaction date: 2026-03-16; grant of 12,000 shares at $0.00 (code A).
  • Form 4 filed: 2026-03-18 (no late-filing indication in the provided data).
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes/notable items: filing does not detail vesting schedule, whether these are restricted shares or RSUs, or any tax-withholding arrangements.

Context

  • A $0.00 acquisition typically means the shares were issued as compensation (e.g., restricted stock or performance award). Such awards align director incentives with shareholders but are not the same signal as an open-market purchase. Vesting conditions or transfer restrictions (if any) will determine when the director can sell the shares.

Insider Transaction Report

Form 4
Period: 2026-03-16
Transactions
  • Award

    Common Stock

    2026-03-16+12,000130,250 total
Signature
/s/ Duncan Gilmour, Attorney-in-Fact for Joseph W. Dews IV|2026-03-18

Documents

2 files
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

  • EX-24.1